Protocol for Assessing the Feasibility of Developing a Predictive Methodology for Evaluating Representativeness in Ongoing Randomised Controlled Trials
Year: 2025
Type: preprint
Study design: Study Protocol
Abstract: This project aims to address a critical gap in clinical research by exploring how to better assess the representativeness of participants in ongoing pharmacological randomised controlled trials (RCTs). While equity and inclusion in trials are increasingly emphasised, there is currently no systematic way to evaluate whether trial populations reflect the diversity of patients seen in real-world clinical practice. Existing horizon scanning and early awareness systems focus on innovation and evidence gaps but do not assess whether ongoing trials are likely to produce findings that are broadly applicable. This project will assess the feasibility of developing a predictive methodology that uses available trial registration and published protocols data to assess the likelihood of enrolling diverse and representative participants. Key demographic and trial-level variables will be extracted and mapped to indicators of representativeness using the PROGRESS-Plus framework. By integrating this approach into early intelligence-gathering processes, the goal is to provide funders, regulators, and researchers with tools to identify and address inclusion gaps earlier in the research pipeline, improving the real-world relevance and equity of clinical evidence.
Source: OSF Preprints (OSF Preprints)
Authors: Jane Nesworthy, Tafadzwa Patience Kunonga, Chizoba Oparah, Opeyemi Agbeleye, Hannah O'Keefe, Gill Norman
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7113073891
